Menu
Back to Journals » Vascular Health and Risk Management » Volume 6 » default
Vascular Health and Risk Management
ISSN: 1178-2048
- View all (1472)
- Volume 19, 2023 (62)
- Volume 18, 2022 (87)
- Volume 17, 2021 (80)
- Volume 16, 2020 (60)
- Volume 15, 2019 (54)
- Volume 14, 2018 (42)
- Volume 13, 2017 (54)
- Volume 12, 2016 (52)
- Volume 11, 2015 (66)
- Volume 10, 2014 (74)
- Volume 9, 2013 (73)
- Volume 8, 2012 (74)
- Volume 7, 2011 (92)
- Volume 6, 2010 (113)
- Volume 5, 2009 (112)
- Volume 4, 2008 (164)
- Volume 3, 2007 (113)
- Volume 2, 2006 (57)
- Volume 1, 2005 (43)
Archive: Volume 6, 2010
COSEHC global vascular risk management quality improvement program: rationale and design
Carlos M Ferrario, Michael A Moore, William Bestermann Jr, et al
Vascular Health and Risk Management 2010, 6:1135-1145
Published Date: 13 December 2010
Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing
Emily Dey-Hazra, Barbara Hertel, Torsten Kirsch, et al
Vascular Health and Risk Management 2010, 6:1125-1133
Published Date: 6 December 2010
Inhaled treprostinil and pulmonary arterial hypertension
Samuel T Nadler, Jeffrey D Edelman
Vascular Health and Risk Management 2010, 6:1115-1124
Published Date: 3 December 2010
Stent-grafts in the management of life-threatening hemorrhage following inadvertent femoral catheterization in high-risk patients: report of two cases and review of the literature
Abdullah Al Wahbi
Vascular Health and Risk Management 2010, 6:1111-1114
Published Date: 3 December 2010
Lower extremity arterial injuries over a six-year period: outcomes, risk factors, and management
Aşkin Ender Topal, Mehmet Nesimi Eren, Yusuf Celik
Vascular Health and Risk Management 2010, 6:1103-1110
Published Date: 3 December 2010
Insulin therapy in critically ill patients
Samer Ellahham
Vascular Health and Risk Management 2010, 6:1089-1101
Published Date: 1 December 2010
Optimal management of familial hypercholesterolemia: treatment and management strategies
Mohammad Hassan Nemati, Behrooz Astaneh
Vascular Health and Risk Management 2010, 6:1079-1088
Published Date: 3 December 2010
Percutaneous coronary intervention of a single coronary artery arising from the right sinus of Valsalva
Mehmet Akif Cakar, Ersan Tatli, Bilhan Ozalp, et al
Vascular Health and Risk Management 2010, 6:1077-1078
Published Date: 25 November 2010
Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
William Insull Jr, Peter P Toth, H Robert Superko, et al
Vascular Health and Risk Management 2010, 6:1065-1075
Published Date: 24 November 2010
Cardio classics revisited – focus on the role of candesartan
Maria Leonarda De Rosa
Vascular Health and Risk Management 2010, 6:1047-1063
Published Date: 23 November 2010
Computerized history-taking as a tool to manage dyslipidemia
David Zakim, Christine Fritz, Niko Braun, et al
Vascular Health and Risk Management 2010, 6:1039-1046
Published Date: 12 November 2010
Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia
Ian Hamilton-Craig, Karam Kostner, David Colquhoun, et al
Vascular Health and Risk Management 2010, 6:1023-1037
Published Date: 10 November 2010
Prognostic value of changes in arterial stiffness in men with coronary artery disease
Iana A Orlova, Eradzh Yu Nuraliev, Elena B Yarovaya, et al
Vascular Health and Risk Management 2010, 6:1015-1021
Published Date: 4 November 2010
Effects of safflower seed extract on arterial stiffness
Katsuya Suzuki, Shigekazu Tsubaki, Masami Fujita, et al
Vascular Health and Risk Management 2010, 6:1007-1014
Published Date: 3 November 2010
Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
Jun Sasaki
Vascular Health and Risk Management 2010, 6:997-1005
Published Date: 2 November 2010
Low high-density lipoprotein cholesterol: current status and future strategies for management
Vibhuti Singh, Rakesh Sharma, Ajoy Kumar, et al
Vascular Health and Risk Management 2010, 6:979-996
Published Date: 29 October 2010
Ticagrelor: An investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome
Eitan Abergel, Eugenia Nikolsky
Vascular Health and Risk Management 2010, 6:963-977
Published Date: 19 October 2010
Hypothyroidism and the risk of lower extremity arterial disease
Michael A Mazzeffi, Hung-Mo Lin, Brigid C Flynn, et al
Vascular Health and Risk Management 2010, 6:957-962
Published Date: 20 October 2010
Risk assessment and aspirin use in Asian and Western populations
Runlin Gao, Xiaoying Li
Vascular Health and Risk Management 2010, 6:943-956
Published Date: 14 October 2010
Diagnostic accuracy of dual-source CT angiography and coronary risk stratification
Xia Yang, Lu-yue Gai, Ping Li, et al
Vascular Health and Risk Management 2010, 6:935-941
Published Date: 14 October 2010
Impact of a diabetic foot care education program on lower limb amputation rate
Abdullah M Al-Wahbi
Vascular Health and Risk Management 2010, 6:923-934
Published Date: 11 October 2010
Small coronary vessel angioplasty: outcomes and technical considerations
Sudhir Rathore
Vascular Health and Risk Management 2010, 6:915-922
Published Date: 11 October 2010
Costs and outcomes of noncardioembolic ischemic stroke in a managed care population
Nicole M Engel-Nitz, Stephen D Sander, Carolyn Harley, et al
Vascular Health and Risk Management 2010, 6:905-913
Published Date: 5 October 2010
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
Christina Voulgari, Dimitrios Papadogiannis, Nicholas Tentolouris
Vascular Health and Risk Management 2010, 6:883-903
Published Date: 11 October 2010
New class of agents for treatment of hypertension: Focus on direct renin inhibition
Roberto Fogari, Annalisa Zoppi
Vascular Health and Risk Management 2010, 6:869-882
Published Date: 1 October 2010
Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update
Juan V Llau, Raquel Ferrandis, Pilar Sierra, et al
Vascular Health and Risk Management 2010, 6:855-867
Published Date: 29 September 2010
Benefits of statin therapy and compliance in high risk cardiovascular patients
Joel A Lardizabal, Prakash C Deedwania
Vascular Health and Risk Management 2010, 6:843-853
Published Date: 23 September 2010
Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study
Laura J Gray, Jennifer R Tringham, Melanie J Davies, et al
Vascular Health and Risk Management 2010, 6:837-842
Published Date: 20 September 2010
Lifestyle diseases and cardiovascular risk factors are interrelated to deficiencies of major substrates in ATP synthesis
Jørn Ditzel, Hans-Henrik Lervang
Vascular Health and Risk Management 2010, 6:829-836
Published Date: 17 September 2010
Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients
Maurizio Destro, Nora Crikelair, Joseph Yen, et al.
Vascular Health and Risk Management 2010, 6:821-827
Published Date: 6 September 2010
Argatroban in the management of heparin-induced thrombocytopenia
Luciano Babuin, Vittorio Pengo
Vascular Health and Risk Management 2010, 6:813-819
Published Date: 1 September 2010
Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice
Peter Bramlage, Wolf-Peter Wolf, Thomas Stuhr, et al
Vascular Health and Risk Management 2010, 6:803-811
Published Date: 27 August 2010
Management of acute attacks of hereditary angioedema: potential role of icatibant
Hilary J Longhurst
Vascular Health and Risk Management 2010, 6:795-802
Published Date: 6 September 2010
Role of endothelin receptor A and NADPH oxidase in vascular abnormalities
De-Zai Dai, Yin Dai
Vascular Health and Risk Management 2010, 6:787-794
Published Date: 3 September 2010
Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review
Suzanne A Ligthart, Eric P Moll van Charante, Willem A Van Gool, et al
Vascular Health and Risk Management 2010, 6:775-785
Published Date: 17 August 2010
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization
Richard Kones
Vascular Health and Risk Management 2010, 6:749-774
Published Date: 12 August 2010
Effectiveness of percutaneous laser revascularization therapy for refractory angina
Michael McGillion, Allison Cook, J Charles Victor, et al
Vascular Health and Risk Management 2010, 6:735-747
Published Date: 26 August 2010
Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells
Myriam Iglewski, Stephen R Grant
Vascular Health and Risk Management 2010, 6:723-734
Published Date: 11 August 2010
Aliskiren and valsartan combination therapy for the management of hypertension
Benjamin J Epstein
Vascular Health and Risk Management 2010, 6:711-722
Published Date: 11 August 2010
Role of olmesartan in combination therapy in blood pressure control and vascular function
Carlos M Ferrario, Ronald D Smith
Vascular Health and Risk Management 2010, 6:701-709
Published Date: 9 August 2010
The utility of troponin measurement to detect myocardial infarction: review of the current findings
Melissa A Daubert, Allen Jeremias
Vascular Health and Risk Management 2010, 6:691-699
Published Date: 5 August 2010
Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment
Curtis Triplitt, Eugenio Cersosimo, Ralph A DeFronzo
Vascular Health and Risk Management 2010, 6:671-690
Published Date: 5 August 2010
Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
Ajoy Kumar, Vibhuti Singh
Vascular Health and Risk Management 2010, 6:665-669
Published Date: 30 July 2010
Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
Elmir Omerovic, Truls Råmunddal, Per Albertsson, et al
Vascular Health and Risk Management 2010, 6:657-663
Published Date: 26 August 2010
Recent advances in the management of chronic stable angina I: Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities
Richard Kones
Vascular Health and Risk Management 2010, 6:635-656
Published Date: 15 July 2010
MRI sagittal abdominal diameter is a stronger predictor of metabolic syndrome than visceral fat area or waist circumference in a high-risk vascular cohort
Michel R Hoenig
Vascular Health and Risk Management 2010, 6:629-633
Published Date: 16 July 2010
Estimating glomerular filtration rate in a population-based study
Anoop Shankar, Kristine E Lee, Barbara EK Klein, et al
Vascular Health and Risk Management 2010, 6:619-627
Published Date: 16 July 2010
Management of high-risk popliteal vascular blunt trauma: clinical experience with 62 cases
Ali Pourzand, Bassir A Fakhri, Ramin Azhough, et al
Vascular Health and Risk Management 2010, 6:613-618
Published Date: 14 July 2010
Cardiac risk stratification: Role of the coronary calcium score
Rakesh K Sharma, Rajiv K Sharma, Donald J Voelker, et al
Vascular Health and Risk Management 2010, 6:603-611
Published Date: 14 July 2010
Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy
Claudio A Muratore, Adrian Baranchuk
Vascular Health and Risk Management 2010, 6:593-601
Published Date: 14 July 2010
Using noncontrast cardiac CT and coronary artery calcification measurements for cardiovascular risk assessment and management in asymptomatic adults
John A Rumberger
Vascular Health and Risk Management 2010, 6:579-591
Published Date: 7 July 2010
Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome
Kanako Bokuda, Atsuhiro Ichihara, Mariyo Sakoda, et al
Vascular Health and Risk Management 2010, 6:571-578
Published Date: 5 July 2010
Practical recommendations for treatment of hypertension in older patients
Philip A Kithas, Mark A Supiano
Vascular Health and Risk Management 2010, 6:561-569
Published Date: 29 June 2010
Blocking the RAAS at different levels: an update on the use of the direct renin inhibitors alone and in combination
Francesca Cagnoni, Christian Achiri Ngu Njwe, Augusto Zaninelli, et al
Vascular Health and Risk Management 2010, 6:549-559
Published Date: 28 June 2010
Weight neutrality with the DPP-4 inhibitor, vildagliptin: Mechanistic basis and clinical experience
James E Foley, Jens Jordan
Vascular Health and Risk Management 2010, 6:541-548
Published Date: 1 July 2010
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
Elisavet Moutzouri, Anastazia Kei, Moses S Elisaf, et al
Vascular Health and Risk Management 2010, 6:525-539
Published Date: 29 June 2010
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
Deborah Wolbrette, Mario Gonzalez, Soraya Samii, et al
Vascular Health and Risk Management 2010, 6:517-523
Published Date: 28 June 2010
Clinical profile of hypertension at a University Teaching Hospital in Nigeria
Arthur C Onwuchekwa, Sunday Chinenye
Vascular Health and Risk Management 2010, 6:511-516
Published Date: 1 July 2010
Transradial approach to lower extremity interventions
Ravikiran Korabathina, Sidharth S Yadav, John T Coppola, et al
Vascular Health and Risk Management 2010, 6:503-509
Published Date: 1 July 2010
Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG
Sandra Eifert, Helmut Mair, Anne-Laure Boulesteix, et al
Vascular Health and Risk Management 2010, 6:495-501
Published Date: 29 June 2010
Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection
Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al
Vascular Health and Risk Management 2010, 6:479-494
Published Date: 22 June 2010
Congestive heart failure in subjects with thyrotoxicosis in a black community
R C Anakwue, B J C Onwubere, B C Anisiuba, et al
Vascular Health and Risk Management 2010, 6:473-477
Published Date: 5 July 2010
Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia
Hugo Van Herendael, Paul Dorian
Vascular Health and Risk Management 2010, 6:465-472
Published Date: 21 June 2010
Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review
Ahmed S Awad, Michael E Goldberg
Vascular Health and Risk Management 2010, 6:457-464
Published Date: 9 June 2010
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure
Inder S Anand, Anita Deswal, Dean J Kereiakes, et al
Vascular Health and Risk Management 2010, 6:449-455
Published Date: 1 June 2010
Novel approaches for the surgical treatment of atrial fibrillation: Time for a guideline revision?
Carlo Nicola De Cecco, Vitaliano Buffa, Vincenzo David, et al
Vascular Health and Risk Management 2010, 6:439-447
Published Date: 9 June 2010
Influence of demographic and metabolic variables on forearm blood flow and vascular conductance in individuals without overt heart disease
Thiago E Sartori, Rafael AB Nunes, Gisela T da Silva, et al
Vascular Health and Risk Management 2010, 6:431-437
Published Date: 31 May 2010
Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor
Margaret M Marczewski, Marek Postula, Dariusz Kosior
Vascular Health and Risk Management 2010, 6:419-429
Published Date: 24 May 2010
Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
A Palazzuoli, M Gallotta, I Quatrini, et al
Vascular Health and Risk Management 2010, 6:411-418
Published Date: 26 May 2010
An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog
Katarina Raslova
Vascular Health and Risk Management 2010, 6:399-410
Published Date: 24 May 2010
Heart rate control with adrenergic blockade: Clinical outcomes in cardiovascular medicine
David Feldman, Terry S Elton, Doron M Menachemi, et al
Vascular Health and Risk Management 2010, 6:387-397
Published Date: 24 May 2010
Isolated spontaneous dissection of the celiac trunk in a patient with bicuspid aortic valve
Abdel-Rauf Zeina, Alicia Nachtigal, Anton Troitsa, et al
Vascular Health and Risk Management 2010, 6:383-386
Published Date: 19 May 2010
Relationship between natriuretic peptides and echocardiography parameters in patients with poorly regulated type 2 diabetes
Magnus Dencker, Martin Stagmo, Mozhgan Dorkhan
Vascular Health and Risk Management 2010, 6:373-382
Published Date: 18 May 2010
Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence
Janet B McGill
Vascular Health and Risk Management 2010, 6:363-372
Published Date: 26 May 2010
Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia
Peter Alagona Jr
Vascular Health and Risk Management 2010, 6:351-362
Published Date: 13 May 2010
New options with dabigatran etexilate in anticoagulant therapy
Lars Maegdefessel, Joshua M Spin, Junya Azuma, et al
Vascular Health and Risk Management 2010, 6:339-349
Published Date: 10 May 2010
Should we screen for masked hypertension in patient with vascular disease?
Pascal Delsart, Philippe Marboeuf, Cedric Delhaye, et al
Vascular Health and Risk Management 2010, 6:333-338
Published Date: 10 May 2010
Effect of lipopenic and hypotensive treatment on homocysteine levels in type 2 diabetics
Mabrouka El Oudi, Zied Aouni, Haroun Ouertani, et al
Vascular Health and Risk Management 2010, 6:327-332
Published Date: 13 May 2010
Optimizing blood pressure control through the use of fixed combinations
Rainer Düsing
Vascular Health and Risk Management 2010, 6:321-325
Published Date: 10 May 2010
Volumetric capnography: In the diagnostic work-up of chronic thromboembolic disease
Marcos Mello Moreira, Renato Giuseppe Giovanni Terzi, Laura Cortellazzi, et al
Vascular Health and Risk Management 2010, 6:317-319
Published Date: 17 May 2010
Coronary computed tomographic angiography (CCTA) in community hospitals: “current and emerging role”
Rakesh K Sharma, Donald J Voelker, Rajiv K Sharma, et al
Vascular Health and Risk Management 2010, 6:307-316
Published Date: 10 May 2010
Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo)
Marco Matteo Ciccone, Ambrogio Aquilino, Francesca Cortese, et al
Vascular Health and Risk Management 2010, 6:297-305
Published Date: 28 April 2010
Mortality following operations for lower extremity peripheral arterial disease
Tracie C Collins, David Nelson, Jasjit S Ahluwalia
Vascular Health and Risk Management 2010, 6:287-296
Published Date: 3 May 2010
Predictors of obstructive sleep apnea in males with metabolic syndrome
Nikolaos Papanas, Paschalis Steiropoulos, Evangelia Nena, et al
Vascular Health and Risk Management 2010, 6:281-286
Published Date: 20 April 2010
The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
Jeremy A Falk, Kiran J Philip, Ernst R Schwarz
Vascular Health and Risk Management 2010, 6:273-280
Published Date: 20 April 2010
Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial
Richard Grimm, Mobin Malik, Carla Yunis, et al
Vascular Health and Risk Management 2010, 6:261-271
Published Date: 16 April 2010
Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update
Maurizio Destro, Francesca Cagnoni, Antonio D’Ospina, et al
Vascular Health and Risk Management 2010, 6:253-260
Published Date: 14 April 2010
Managing anemia in patients with chronic heart failure: what do we know?
Ankur Sandhu, Sandeep Soman, Michael Hudson, et al
Vascular Health and Risk Management 2010, 6:237-252
Published Date: 7 April 2010
Atorvastatin in stroke: a review of SPARCL and subgroup analysis
Branko N Huisa, Andrew B Stemer, Justin A Zivin
Vascular Health and Risk Management 2010, 6:229-236
Published Date: 30 March 2010
Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function
Poulami Basu, Utpal Sen, Neetu Tyagi, et al
Vascular Health and Risk Management 2010, 6:215-228
Published Date: 30 March 2010
Recent achievements in the management of Raynaud’s phenomenon
Magnus Baumhäkel, Michael Böhm
Vascular Health and Risk Management 2010, 6:207-214
Published Date: 30 March 2010
Does plasmin have anticoagulant activity?
Jane Hoover-Plow
Vascular Health and Risk Management 2010, 6:199-205
Published Date: 26 March 2010
Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
Toshikazu Yamanouchi
Vascular Health and Risk Management 2010, 6:189-197
Published Date: 23 March 2010
Fondaparinux and acute coronary syndromes: update on the OASIS 5–6 studies
François Schiele
Vascular Health and Risk Management 2010, 6:179-187
Published Date: 26 March 2010
Advances in the treatment of Raynaud’s phenomenon
Terri L Levien
Vascular Health and Risk Management 2010, 6:167-177
Published Date: 11 March 2010
Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients
Pongsathorn Gojaseni, Angkana Phaopha, Worawon Chailimpamontree, et al
Vascular Health and Risk Management 2010, 6:157-165
Published Date: 11 March 2010
Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
Ajikumar V Aryangat, John E Gerich
Vascular Health and Risk Management 2010, 6:145-155
Published Date: 9 March 2010
The diagnostic value of endothelial function as a potential sensor of fatigue in health
Yoshiko Ohno, Teruto Hashiguchi, Ryuichi Maenosono, et al
Vascular Health and Risk Management 2010, 6:135-144
Published Date: 9 March 2010
New standards in hypertension and cardiovascular risk management: focus on telmisartan
Domenico Galzerano, Cristina Capogrosso, Sara Di Michele, et al
Vascular Health and Risk Management 2010, 6:113-133
Published Date: 4 March 2010
Aspirin and clopidogrel resistance: methodological challenges and opportunities
Armen Yuri Gasparyan
Vascular Health and Risk Management 2010, 6:109-112
Published Date: 2 March 2010
A newly designed hydroxyapatite ceramic burr-hole button
Hiroshi Kashimura, Kuniaki Ogasawara, Yoshitaka Kubo, et al
Vascular Health and Risk Management 2010, 6:105-108
Published Date: 3 March 2010
Modern role for clopidogrel in management of atrial fibrillation and stroke reduction
Lars Maegdefessel, Junya Azuma, Philip S Tsao
Vascular Health and Risk Management 2010, 6:95-103
Published Date: 26 February 2010
Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine
Roberto Fogari, Amedeo Mugellini, Paola Preti, et al
Vascular Health and Risk Management 2010, 6:87-93
Published Date: 22 February 2010
Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
Yun Lin, Shaymaa S Mousa, Nabil Elshourbagy, et al
Vascular Health and Risk Management 2010, 6:73-85
Published Date: 12 February 2010
On the antiatherogenic effects of vitamin E: the search for the Holy Grail
Francesco Galli, Dimitrios Kirmizis, Dimitrios Chatzidimitriou
Vascular Health and Risk Management 2010, 6:69-71
Published Date: 16 February 2010
Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A
Hans-Christoph Rossbach
Vascular Health and Risk Management 2010, 6:59-68
Published Date: 29 January 2010
Inhaled insulin: overview of a novel route of insulin administration
Lucy D Mastrandrea
Vascular Health and Risk Management 2010, 6:47-58
Published Date: 15 January 2010
Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention
Jennifer Vergara-Jimenez, Pierluigi Tricoci
Vascular Health and Risk Management 2010, 6:39-45
Published Date: 2 March 2010
Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care
Frederic Kontny, Terje Risanger, Arne Bye, et al
Vascular Health and Risk Management 2010, 6:31-38
Published Date: 15 January 2010
Successful management of late right ventricular perforation after pacemaker implantation
Amir K Bigdeli, Andres Beiras-Fernandez, Ingo Kaczmarek, et al
Vascular Health and Risk Management 2010, 6:27-30
Published Date: 6 January 2010
Impact of data from recent clinical trials on strategies for treating patients with type 2 diabetes mellitus
Pasquale J Palumbo, Jonathan M Wert
Vascular Health and Risk Management 2010, 6:17-26
Published Date: 6 January 2010
Role of ICAM-1 and E-selectin gene polymorphisms in pathogenesis of PAOD in Egyptian patients
Olfat Shaker, Amr Zahra, Ahmed Sayed, et al
Vascular Health and Risk Management 2010, 6:9-15
Published Date: 24 December 2009
Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients
Jamison Wyatt, Shailesh Nandish, Rene Oliveros, et al
Vascular Health and Risk Management 2010, 6:1-8
Published Date: 23 December 2009